Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: A phase II study of the Gynecologic Oncology Group
- 1 February 2006
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 100 (2) , 385-388
- https://doi.org/10.1016/j.ygyno.2005.09.009
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Pilot Study of Fixed-Infusion Rate Gemcitabine with Cisplatinand Dexamethasone in Patients with Relapsed or Refractory LymphomaClinical Lymphoma, 2004
- Innovations in the treatment of invasive cervical cancerCancer, 2003
- Stage IIB-IVA Cancer of the CervixThe Cancer Journal, 2003
- The Role of Chemotherapy in the Management of Carcinoma of the CervixThe Cancer Journal, 2003
- Prognostic factors and survival in patients with metastatic or recurrent carcinoma of the uterine cervixInternational Journal of Gynecologic Cancer, 2003
- Gemcitabine Reverses Cisplatin Resistance: Demonstration of Activity in Platinum- and Multidrug-Resistant Ovarian and Peritoneal CarcinomaGynecologic Oncology, 2003
- Phase II Trial of Gemcitabine plus Cisplatin Repeating Doublet Therapy in Previously Treated, Relapsed Ovarian Cancer PatientsGynecologic Oncology, 2003
- Gemcitabine Plus Cisplatin Repeating Doublet Therapy in Previously Treated, Relapsed Breast Cancer PatientsJournal of Clinical Oncology, 2000
- Evaluation and Comparison of Histopathologic Grading Systems of Epithelial Carcinoma of the Uterine CervixInternational Journal of Gynecological Pathology, 1994
- Carcinoma of the cervix treated with radiation therapy I. A multi-variate analysis of prognostic variables in the gynecologic oncology groupCancer, 1991